Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients-Reference-Cited by-同舟云学术

Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients

Published:2017-08-25 Issue:10 Volume:69 Page:2029-2037
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Kubo Satoshi¹,Nakayamada Shingo¹,Yoshikawa Maiko¹,Miyazaki Yusuke¹,Sakata Kei¹,Nakano Kazuhisa¹,Hanami Kentaro¹,Iwata Shigeru¹,Miyagawa Ippei¹,Saito Kazuyoshi¹,Tanaka Yoshiya¹

Affiliation:

1. University of Occupational and Environmental Health; Kitakyushu Japan

Funder

Ministry of Health, Labour and Welfare

Ministry of Education, Culture, Sports, Science and Technology

National Institute of Occupational Safety and Health, Japan

Grant-In-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan

the University of Occupational and Environmental Health, Japan, through UOEH Grant for Advanced Research

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Reference34 articles.

1. Systemic lupus erythematosus;Kaul;Nat Rev Dis Primers,2016

2. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus;Iwata;Lupus,2015

3. Relevance of lymphocyte subsets to B cell-targeted therapy in systemic lupus erythematosus;Nakayamada;Int J Rheum Dis,2015

4. B cells as therapeutic targets in SLE;Sanz;Nat Rev Rheumatol,2010

5. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity;Lipsky;Nat Immunol,2001

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The molecular subtypes of autoimmune diseases;Computational and Structural Biotechnology Journal;2024-12

2. Immunophenotypes of systemic lupus erythematosus – features of clinical and laboratory disorders;Rheumatology Science and Practice;2024-09-02

3. Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies;Journal of Autoimmunity;2024-09

4. Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus;RMD Open;2024-06

5. Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice;Journal of Autoimmunity;2024-05